bioRxiv Science⌕ Search

Biology subjects

Chamois, S.

Publications and source records attributed to Chamois, S..

3 recordsLinked to original sources

Anisomycin-induced ribosome collisions follow a dose-dependent positional rule, distinct from the UV-induced collision landscape

Ribosome collisions trigger stress pathways such as the ribotoxic stress response (RSR), yet how different ribosome-impairing stimuli shape where collisions form on mRNAs remains unclear. Here, we combine monosome- and disome-resolved ribosome profiling with proteomics of collided-ribosome fractions to compare anisomycin- and UV-induced ribosome impairment in mouse embryonic stem cells. Low-dose anisomycin, a widely used collision-inducing paradigm, does not generate collisions dispersed along transcripts but a post-initiation collision zone, with stalled monosomes and disomes accumulating within the first ~70 nucleotides of coding sequences across most translated mRNAs. High-dose anisomycin, commonly considered collision-poor, produces the same pattern shifted closer to the start codon and reduced in amplitude. These observations support a single dose-dependent positional rule, in which drug occupancy determines how far ribosomes progress before arrest and ongoing initiation supplies trailing ribosomes. In contrast, 30 min after UV irradiation, collisions are detectable biochemically but appear more dispersed, with few recurrent hotspots and preferential accumulation on highly translated mRNAs. Collided-ribosome fractions share enrichment of the collision sensor EDF1 across conditions, whereas recruitment of ZNF598 and initiation factors is most evident after UV. Our results refine the interpretation of anisomycin-based collision paradigms and show that collision landscapes depend on the nature of the stimulus.

molecular biology↗

The 18S rRNA methyltransferase, BUD23, is required for appropriate lipid and mitochondrial metabolism

Efficient energy metabolism is essential for health and its dysregulation drives cardiometabolic disease. Delivery of regulatory control through translation and ribosome function is emerging as important. Here, we identify the rRNA methyltransferase BUD23 as a potent regulator of cellular and systemic energy homeostasis. Adipocyte-specific deletion of BUD23 in mice regulates lipid and mitochondrial metabolism resulting in a pronounced lean phenotype and resistance to diet-induced obesity. Mechanistically, BUD23 modulates translation initiation and efficiency of mRNAs with specific features - including short 5 UTR length and GC-rich post-initiation codon usage - characteristic of mitochondrial and lipogenic proteins. Genetic analyses and Mendelian randomisation support a role for BUD23 in human cardiometabolic traits and disease burden. Together, our findings uncover a conserved translational control mechanism that regulates energy state, from cellular metabolism through to human cardiometabolic health.

cell biology↗

A unique No-Go Decay cleavage in mRNA exit-tunnel of ribosome produces 5’-OH ends phosphorylated by Rlg1

The No-Go Decay (NGD) mRNA surveillance pathway degrades mRNAs containing stacks of stalled ribosomes. Although an endoribonuclease has been proposed to initiate cleavages upstream of the stall sequence, the production of two RNA fragments resulting from a unique cleavage has never been demonstrated. We have used mRNAs expressing a 3-ribozyme to produce truncated transcripts in vivo to mimic naturally occurring truncated mRNAs known to trigger NGD. This technique allows us to analyse endonucleolytic cleavage events at single-nucleotide resolution starting at the third collided ribosome, which we show to be Hel2-dependent. These cleavages map precisely in the mRNA exit tunnel of the ribosome, 8 nucleotides upstream of the first P-site residue and release 5-hydroxylated RNA fragments requiring 5-phosphorylation prior to digestion by the exoribonuclease Xrn1, or alternatively by Dxo1. Finally, we identify the RNA kinase Trl1, alias Rlg1, as an essential player in the degradation of NGD RNAs.

molecular biology↗